Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 15Lymphoid 15Myeloid 11Sarcoma 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 15Neoplasms 3Sarcoma 1Retroperitoneal liposarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Piebaldism 1Neoplasm Metastasis 1Liposarcoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyosarcoma 1Gastrointestinal Neoplasms 1Disease Progression 1Chordoma 1Chondrosarcoma 1

Interventions

Cyclophosphamide 56fludarabine phosphate 40Peripheral Blood Stem Cell Transplantation 32Cyclosporine 32Filgrastim 31Busulfan 31Mycophenolic Acid 30Antilymphocyte Serum 28Radiotherapy 27Whole-Body Irradiation 25Melphalan 23Tacrolimus 18Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Methotrexate 16Etoposide 16Cytarabine 9Thiotepa 8sargramostim 6fludarabine 6aldesleukin 6Sirolimus 6Rituximab 6thymoglobulin 5Therapeutics 5Psychiatric Rehabilitation 5Granulocyte Colony-Stimulating Factor 5Doxorubicin 4Vincristine 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × nilotinib × Sarcoma × Clear all
NCT01735955 2024-02-08

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Novartis

Phase 4 Completed
57 enrolled 8 charts
GastrointestinalLymphoidMyeloidOther hematologic neoplasmSarcoma

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Piebaldism, Gastrointestinal Stromal Tumors, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡